Patheon to feature its capabilities at INTERPHEX JAPAN 2010 convention

Jun 16, 2010, 07:00 ET from Patheon Inc.

RESEARCH TRIANGLE PARK, NC, June 16 /PRNewswire-FirstCall/ - Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry invites customers, potential customers and representatives of the media to visit Patheon's booth number 42-24 in the Pharma Sourcing 2010 area to learn more about the comprehensive service offerings and specialized capabilities it provides to the biopharmaceutical industry.

In 2009, Patheon provided services to approximately 300 customers throughout the world, including 19 of the world's 20 largest pharmaceutical companies, six of the world's 10 largest biotechnology customers and seven of the world's 10 largest specialty pharmaceutical companies. The company manufactured 13 of the 200 top selling drug compounds in the world and its products were distributed in approximately 50 countries. Patheon is currently developing 11 of the top 100 developmental stage drugs in the world on behalf of its customers.

INTERPHEX JAPAN is Asia's largest pharmaceutical industry event with over 1,770 exhibitors that provide insights and inspiration on the major trends in the industry today.


Patheon is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative technologies including single-use disposables, liquid-filled hard capsules and a variety of modified release technologies. Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon can take customers direct to clinic with global clinical packaging and distribution services and Patheon's Quick to Clinic(TM) programs can accelerate early phase development project to clinical trials while minimizing the consumption of valuable API. Patheon's integrated development and manufacturing network of 11 facilities and eight development centers, across North America and Europe, strives to ensure that customer products can be launched timely and confidently anywhere in the world.

SOURCE Patheon Inc.